...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM
3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM

Buckeyes, I think we're all getting lost in the monkey wrench  "Don" threw at us.

Jonzobot said it best over at the Resverlogix Agoracom board:

"Now because he can't find money, he's going to screw up Zenith by selling it's royalties on a gamble to pay for the next RVX trial."

In my opinion, this is all a pipe dream.

I'm surprised we have not heard from KayakerBC on all of this!

 

Koo

 

3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply